We describe here a novel unbalanced whole-arm translocation der(3;10)(q10;q10) in a 58-year-old man with acute monocytic leukemia. Bone marrow was massively infiltrated with 22.2% monoblasts, 55.4% promonocytes and 5.6% monocytes. These monocytic cells were positive for myeloperoxidase and -naphthyl butyrate esterase stainings. Surface marker analysis revealed that they were positive for CD4, CD13, CD33, CD56 and HLA-DR but negative for CD14 and CD34. Chromosome analysis of the bone marrow cells showed 46,XY,+3,der(3;10)(q10;q10)[18]/46,XY [2] . Spectral karyotyping confirmed der(3;10)(q10;q10) as a sole structural abnormality. By acquisition of a normal chromosome 3 but not a chromosome 10, the der(3;10)(q10;q10) resulted in trisomy 3q and monosomy 10p.
Introduction
Acute monoblastic leukemia and acute monocytic leukemia are myeloid leukemias in which 80% or more of the leukemic cells are monocytic lineage including monoblasts, promonocytes and monocytes. In the newly revised World Health Organization (WHO) classification, they are now categorized in "acute myeloid leukemia, not otherwise specified (AML, NOS)" with no recurrent genetic abnormality [1] . Nevertheless, myeloid-associated, non-specific cytogenetic abnormalities are present in the majority of cases.
Unbalanced whole-arm translocations, which involve breakage and reunion of nonhomologous chromosomes at their centromeres, are relatively rare acquired cytogenetic aberrations in hematological malignancies [2] . Some of these translocations, such as der(1;7)(q10;p10), der(7;12)(q10;q10), and der(9;18)(p10;q10), have been reported as a sole and recurrent anomaly, indicating that they could be primary genetic changes [2] [3] [4] [5] . Among them, the most frequent der(1;7)(q10;p10) has been clinically and molecularly characterized. It constitutes a distinct entity in myeloid malignancies including AML and myelodysplastic syndrome (MDS) [3] .
However, clinical importance of other unbalanced whole-arm translocations remains to be completely clarified. We describe here a novel unbalanced whole-arm translocation der(3;10)(q10;q10) in a patient with acute monocytic leukemia.
Materials and methods

Case History
A 58-year-old man was admitted to our hospital because of anemia and leukocytosis in July (Fig. 1A ). They were positive for myeloperoxidase and -naphthyl butyrate (ANB) esterase but negative for chloroacetate esterase stainings (Fig.   1B, 1C ). The ANB positivity was totally inhibited by NaF (Fig. 1D) . Trilineage dysplasia was not apparent in the bone marrow cells. Surface marker analysis with CD45 gating by three-color flow cytometry revealed that the monocytic cells (86.5% of all bone marrow cells)
were positive (more than 20%) for CD4 (48.2%), CD13 (28.7%), CD33 (100.0%), CD56
(94.8%) and HLA-DR (97.0%) but negative for CD14 (7.0%) and CD34 (3.0%). Therefore, we made the diagnosis as AML M5b in the French-American-British classification or acute monocytic leukemia in the WHO classification [1] . An induction therapy with idarubicin and cytosine arabinoside was started, and the patient achieved a complete remission (CR). He is now under consolidation therapy and remained in hematological and cytogenetic CR for four months.
Chromosome and fluorescence in situ hybridization (FISH) analyses
Chromosome analyses were performed by the G-banding technique on unstimulated short-term culture of the cells obtained from bone marrow at the initial diagnosis and after CR.
Karyotypes were described according to ISCN 2009 [6] . Spectral karyotyping (SKY) was car- 
Results
Chromosome analysis of the bone marrow cells at the initial diagnosis of acute monocytic leukemia showed 46,XY,+3,der(3;10)(q10;q10) [18] /46,XY [2] (Fig. 2A) . SKY analysis confirmed der(3;10)(q10;q10) as a sole structural abnormality (Fig. 2B) 
Discussion
We have identified a novel unbalanced whole-arm translocation der(3;10)(q10;q10) in acute monocytic leukemia. To the best of our knowledge, the der(3;10)(q10;q10) has never been described in the literature to date [7] . Furthermore, the der(3;10) was accompanied by an extra chromosome 3. Duplication of a normal copy of one of the chromosomes participating in the translocation occurs in more than one half of the cases with unbalanced translocations [8] , such as +1,der(1;7)(q10;p10) and der(5;19)(p10;q10),+19 [3, 9] . In the present case, by acquisition of a normal chromosome 3 but not a chromosome 10, the der(3;10) resulted in trisomy 3q and monosomy 10p. The +3,der(3;10) was found as a sole abnormality in all abnormal metaphase spreads by G-banding, indicating that it could play a crucial role in the pathogenesis of acute monocytic leukemia by the gain of 3q or the loss of 10p. Both unbalanced aberrations are not described in cytogenetic abnormalities sufficient to diagnose AML with myelodysplasia-related features in the WHO classification [10] . Thus, considering the absence of previous history of MDS and multilineage dysplasia in the bone marrow, we diagnosed the disease as de novo acute monocytic leukemia.
The most significant consequence of unbalanced whole-arm translocation is the genomic imbalance resulting from the gain and loss of whole chromosome arms. Adeyinka et al. [2] reported that chromosome arms were non-randomly involved in the whole-arm translocations.
That is, a loss of 17p was most common, and losses of 7q, 13p, 14p, and 15p, and a gain of 1q
were found in more than 10% of cases in 131 hematological malignancies. A gain of 3q and a loss of 10p were observed in three and seven cases, respectively, although the karyotypes of these cases were not fully described. According to the Mitelman database [7] , unbalanced whole-arm translocations involving 3q10 or 10q10 were found in 19 cases and 13 cases of hematological malignancies, respectively. Among them, 10 cases of MDS/AML with 3q10 or 10q10 translocations are summarized in Table 1 caused by unbalanced whole-arm translocations seems to be a very rare event in MDS/AML.
Another two cases with 10q10 translocations (No. 9 and 10) showed monosomy 10p.
Whole or partial trisomy 3 has been reported to be especially associated with lymphoid malignancies. Trisomy 3 represents the most frequent chromosomal abnormality in marginal zone B-cell lymphoma (MZBCL) [19] . Partial trisomy 3q induced by unbalanced translocations involving chromosome 3 is recurrently found in MZBCL as well, and a commonly duplicated region was found to be 3q13.2-3q29 [20] . In addition to MZBCL, gains of chromosome 3/3q occur in other lymphoid B-cell chronic lymphoproliferative disorders including chronic lymphocytic lymphoma, prolymphocytic leukemia and Waldenström's macroglobulinemia [21] . In myeloid malignancies, a few cases of childhood AML showed trisomy 3 and tetrasomy 3q [22] .
Gains of partial chromosome 3q by unbalanced translocations were also reported in cases of juvenile myelomonocytic leukemia [23] .
The underlying genetic mechanism by trisomy 3/3q is supposed to be a gene dosage effect rather than a specific gene disruption [20] . Several genes of particular importance in neoplastic transformation are included in the chromosome 3q, such as PARP9 (BAL) at 3q13-21, RPN1 at 3q21.3, PBX2P1 at 3q24, MECOM (MDS1-EVI1) at 3q26, TERC (hTR) at 3q26.2, and BCL6 at 3q27 [20, 22] . However, it is unknown whether these genes have a gene dosage effect by trisomy 3/3q. On the other hand, monosomy 10p, which could be considered as an alternative mechanism to development of leukemia, has been hardly shown to be correlated with specific subtypes of hematological malignancies. Thus, accumulation of more cases will be necessary to clarify the critical role of der(3;10) in the pathogenesis of acute monocytic leukemia. 
Figure legends
